Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.
about
Proteomic indicators of oxidation and hydration state in colorectal cancerGlycomics expression analysis of sulfated glycosaminoglycans of human colorectal cancer tissues and non-neoplastic mucosa by electrospray ionization mass spectrometryLinking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressivenessSorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.Chemical composition and the potential for proteomic transformation in cancer, hypoxia, and hyperosmotic stressDetecting Significant Changes in Protein AbundanceEPMA position paper in cancer: current overview and future perspectives.The mechanism of Jurkat cells apoptosis induced by Aggregatibacter actinomycetemcomitans cytolethal distending toxin.Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.An insight into iTRAQ: where do we stand now?Quantitative mass spectrometry for colorectal cancer proteomics.Biomarkers of colorectal cancer: recent advances and future challenges.Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.Quantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomas.Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases.
P2860
Q28829212-D078AA77-3B0E-4CF2-BDEC-8075F1A7B605Q30383485-3E02A7F0-C03D-4EF6-BA02-6B6908B461BFQ30975797-7F1C23C6-383A-4F53-97D1-BBCCF82A0B0AQ33583152-DF5F128C-D3FC-4FB6-AE5E-1EBC979F51CFQ33777591-A077B95A-72BD-4955-B590-656B5E736173Q35215673-84AF911B-2486-4774-AF59-2A35398293C1Q35532215-6B311A1B-C1E8-4755-86B1-34845687DEF0Q36293421-D1EBECB6-E68E-414B-B8D5-7926CC4CA551Q36588615-9079482A-95F2-4BD9-9B83-2EAC88521C01Q36662001-EAE337A1-E3B3-47DB-A2F6-F947E4009795Q37997372-2C43F7CE-2040-4752-9351-097EA434C61EQ38048726-52FDE973-B39B-4DF8-A329-4FFA5C74DFCDQ38259770-242BCE28-7D2A-445E-BDD6-51FD59AE2BCBQ38652227-5E02EC8F-84CC-498B-A1F1-EA3F2F728AEEQ55026142-72CCEA5A-B24E-4F94-B01D-1BF0362B3E76Q55315602-AD6B0900-6094-4918-941A-CA11EE78AEB4
P2860
Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Proteomic comparison of colore ...... using iTRAQ mass spectrometry.
@en
type
label
Proteomic comparison of colore ...... using iTRAQ mass spectrometry.
@en
prefLabel
Proteomic comparison of colore ...... using iTRAQ mass spectrometry.
@en
P2093
P2860
P50
P356
P1433
P1476
Proteomic comparison of colore ...... using iTRAQ mass spectrometry
@en
P2093
Caroline L S Fung
Charles Chan
Elie L Bokey
Graham R Robertson
Lucy Jankova
Owen F Dent
Pierre H Chapuis
Stephen J Clarke
Sun Y Kwun
Warren Kaplan
P2860
P304
P356
10.1039/C1MB05236E
P577
2011-08-02T00:00:00Z